A detailed history of Prosight Management, LP transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Prosight Management, LP holds 599,460 shares of MRVI stock, worth $4.19 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares
599,460
Holding current value
$4.19 Million
% of portfolio
1.49%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$5.11 - $8.76 $3.06 Million - $5.25 Million
599,460 New
599,460 $5.2 Million
Q2 2023

Aug 14, 2023

BUY
$12.09 - $15.0 $3.8 Million - $4.71 Million
314,300 New
314,300 $3.91 Million
Q3 2022

Nov 14, 2022

BUY
$20.6 - $30.37 $175,924 - $259,359
8,540 New
8,540 $218,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $919M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Prosight Management, LP Portfolio

Follow Prosight Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.